ARCA biopharma (ABIO) has the following price history information. Looking back at ABIO historical stock prices for the last five trading days, on November 22, 2023, ABIO opened at $1.89, traded as high as $1.89 and as low as $1.85, and closed at $1.87. Trading volume was a total of 12.50K shares. On November 24, 2023, ABIO opened at $1.86, traded as high as $1.95 and as low as $1.86, and closed at $1.95. Trading volume was a total of 23.50K shares. On November 27, 2023, ABIO opened at $1.95, traded as high as $1.95 and as low as $1.91, and closed at $1.94. Trading volume was a total of 12.40K shares. On November 28, 2023, ABIO opened at $1.95, traded as high as $1.95 and as low as $1.89, and closed at $1.90. Trading volume was a total of 6.00K shares. On November 29, 2023, ABIO opened at $1.88, traded as high as $1.94 and as low as $1.88, and closed at $1.90. Trading volume was a total of 28.40K shares.

ABIO Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014201520162017201820192020202120222023

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ARCA biopharma shares, starting with a $10,000 purchase of ABIO, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	12/02/2013
End date:	11/29/2023
Start price/share:	$177.66
End price/share:	$1.90
Dividends collected/share:	$0.00
Total return:	-98.93%
Average Annual Total Return:	-36.49%
Starting investment:	$10,000.00
Ending investment:	$106.90
Years:	10.00

ABIO Historical Price Range
Date	Open	High	Low	Close	Volume
11/22/2023	$1.89	$1.89	$1.85	$1.87	12.50K
11/24/2023	$1.86	$1.95	$1.86	$1.95	23.50K
11/27/2023	$1.95	$1.95	$1.91	$1.94	12.40K
11/28/2023	$1.95	$1.95	$1.89	$1.90	6.00K
11/29/2023	$1.88	$1.94	$1.88	$1.90	28.40K

About ARCA biopharma

ARCA biopharma is a clinical-stage biopharmaceutical company. Co.'s primary product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2 (AB201)) as a potential treatment for COVID-19, the disease syndrome caused by the SARS-CoV-2 virus, and potentially other viral diseases and Gencaro™ (bucindolol hydrochloride) for the treatment of atrial fibrillation in patients with chronic heart failure. rNAPc2 targets COVID-19 patients with biomarker evidence of coagulopathy, while Gencaro is being developed for patients who have a genotype that identifies a drug target associated with heightened efficacy.

ABIO Historical Closing Prices
Date	Close
11/22/2023	$1.87
11/24/2023	$1.95
11/27/2023	$1.94
11/28/2023	$1.90
11/29/2023	$1.90

Healthcare Historical Prices

ABIO is categorized under the Healthcare sector; below are some other companies in the same sector: ABMD Historical Stock Prices ABT Historical Stock Prices ABV Historical Stock Prices ACAD Historical Stock Prices ACER Historical Stock Prices ACET Historical Stock Prices ACHC Historical Stock Prices ACHN Historical Stock Prices ACHV Historical Stock Prices ACOR Historical Stock Prices Also explore: ABIO shares outstanding history Free ABIO Email Alerts: Get Dividend Alerts Get SEC Filing Alerts

ABIO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.